These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31226034)

  • 1. Sham trials: benefits and risks for cardiovascular research and patients.
    Fudim M; Ali-Ahmed F; Patel MR; Sobotka PA
    Lancet; 2019 May; 393(10186):2104-2106. PubMed ID: 31226034
    [No Abstract]   [Full Text] [Related]  

  • 2. Sham-Controlled Trials for Coronary Interventions: Ethically Acceptable and Ethically Important.
    Dickert NW; Miller FG
    J Am Coll Cardiol; 2018 Jan; 71(1):95-97. PubMed ID: 29301633
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sham-Controlled Trial Questions Benefit of Stents for Stable Angina.
    Kuehn BM
    Circulation; 2018 Jan; 137(5):519-520. PubMed ID: 29378758
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary Stent Placement in Patients with Stable Angina - an Ongoing Debate.
    Korr KS
    R I Med J (2013); 2018 Mar; 101(2):10-11. PubMed ID: 29490315
    [No Abstract]   [Full Text] [Related]  

  • 6. A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris.
    Thomas S; Gokhale R; Boden WE; Devereaux PJ
    Can J Cardiol; 2013 Apr; 29(4):472-82. PubMed ID: 23010084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris.
    Shkolnik E; Burneikaite G; Jakutis G; Scherbak M; Zuoziene G; Petrauskiene B; Trush E; Vasyuk Y; Laucevicius A; Celutkiene J
    Coron Artery Dis; 2018 Nov; 29(7):579-586. PubMed ID: 29912782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking revascularization in patients with stable angina.
    Harskamp RE; Park DW
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):159-161. PubMed ID: 29338462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the place of percutaneous coronary intervention in the management of stable angina?
    Escobar C; Barrios V
    Hellenic J Cardiol; 2012; 53(3):249-50. PubMed ID: 22653252
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI.
    Lampropoulos K; Megalou A; Bazoukis G; Tse G; Manolis A
    J Interv Cardiol; 2017 Dec; 30(6):507-513. PubMed ID: 28786142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting may not be required before percutaneous coronary intervention.
    Aguilar-Nascimento JE; Feguri GR
    Evid Based Nurs; 2015 Apr; 18(2):41. PubMed ID: 25163472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papering over the cracks: meta-analysis to define the role of percutaneous coronary intervention in patients with stable angina.
    Waters DD
    Can J Cardiol; 2013 Apr; 29(4):411-4. PubMed ID: 22985786
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study.
    Shkolnik E; Burneikaite G; Celutkiene J; Scherbak M; Zuoziene G; Petrauskiene B; Trush E; Laucevicius A; Vasyuk Y
    Anatol J Cardiol; 2018 Feb; 19(2):100-109. PubMed ID: 29424731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current Treatment of Stable Angina].
    Toggweiler S; Jamshidi P; Cuculi F
    Praxis (Bern 1994); 2015 Jun; 104(13):681-7. PubMed ID: 26081380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to optimize left main percutaneous coronary intervention.
    Park SJ; Ahn JM; Kim YH
    JACC Cardiovasc Interv; 2014 Jul; 7(7):731-2. PubMed ID: 25060014
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.
    Khattab AA; Knecht M; Meier B; Windecker S; Schmid JP; Wilhelm M; Saner H
    Eur J Prev Cardiol; 2013 Oct; 20(5):743-9. PubMed ID: 22547410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal denervation as treatment option for hypertension].
    Blankestijn PJ; Bots ML
    Ned Tijdschr Geneeskd; 2016; 160():D629. PubMed ID: 27781967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.